PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

720

Participants

Timeline

Start Date

December 23, 2009

Primary Completion Date

January 15, 2014

Study Completion Date

November 27, 2015

Conditions
Lung Cancer
Interventions
DRUG

PF-00299804

PF-804 45 mg PO, daily

DRUG

Placebo

Placebo 45 mg PO, daily

Trial Locations (89)

18

Hospital Central De La Fuerza Aerea Del Peru, Lima

114

Tri-Service General Hospital, Taipei

404

China Medical University Hospital, Taichung

736

Chi-Mei Foundation Hospital, Tainan City

1000

Phillippine General Hospital, Manila

1023

Auckland City Hospital, Auckland

1229

Makati Medical Center, Makati City

2031

Prince of Wales Hospital, Randwick

2050

Royal Prince Alfred Hospital, Camperdown

2065

Royal North Shore Hospital, St Leonards

2139

Concord Repatriation General Hospital, Concord

2145

Westmead Hospital, Westmead

2217

St. George Hospital, Cancer Care Centre, Kogarah

2298

Calvary Mater Newcastle Hospital, Waratah

3011

Western Hospital, Footscray

3084

Austin Hospital, Heidelberg

3168

Monash Medical Centre, Clayton

3199

Frankston Hospital - Peninsula Oncology Centre, Frankston

3220

Geelong Hospital, Geelong

4032

The Prince Charles Hospital, Chermside

4560

Nambour General Hospital, Nambour

5000

Royal Adelaide Hospital, Adelaide

6000

Perpetual Succour Hospital, Cebu City

6009

Sir Charles Gairdner Hospital, Perth

10330

Chulalongkorn University, Bangkok

10400

Ramathibodi Hospital, Bangkok

10700

Siriraj Hospital, Oncology Unit, Bangkok

16149

U.O. di Oncologia Ospedale Villa Scassi, Genova

20132

Ospedale San Raffaele, Milan

21047

A.O. Busto Arsizio - P.O. Saronno, Saronno

23039

Ospedale E. Morelli-Sondalo, Sondalo

29100

Azienda USL di Piacenza, Ospedale Gugliemimo Salieto, Piacenza

30035

U.O.C. di Oncologia U.L.S.S. 13, Mirano

33081

Centro di Riferimento Oncologico - CRO, Aviano

35128

UOC Oncologia Medica II Instituto Oncologio Veneto, Padua

47014

Intstituto Scientifico Romangnolo, Meldola

50200

Maharaj Nakorn Chiangmai Hospital, Chiang Mai

60077

Clintell, Inc., Skokie

61032

Ospedale Santa Croce, Fano

71013

Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo

80131

Dott. Fortunato Ciardiello,Cattedra Oncologia Medica, Napoli

Unita Sperimentazioni Cliniche Istituto per lo, Napoli

82100

U.O. di Oncologia Medica Azienda Ospedaliera G Rummo, Benevento

91007

Shapiro, Stafford and Yee, Arcadia

98125

U.O.C. Terapie Integrate in Oncologia,, Messina

98158

U.O.C. Oncologia Medica,, Messina

Unknown

CER - Instituto Medico, Buenos Aires

Damic-Fundacion Rusculleda, Córdoba

La Maddalena, Dipartimento Oncologico, Palermo

Hospital Nacional Luis N. Saenz, Lima

Instituto de Oncologia y Radioterapia de, Lima

01884

COIBA Centro de Oncologia e Investigacion, Berazategui

T4000IAK

Centro Medico San Roque, San Miguel de Tucumán

90840-440

Centro de Oncologia e Radioterapia (COR) Mae de Deus, Porto Alegre

14784-400

Fundacao Pio XII - Hospital de Cancer de Barretos, Barretos

01321-001

ESHO - Empresa de Servicos Hospitalares Ltda., Brasilia

17210-120

Centro de Pesquisa Clinica do Hospital, Porto Alegre

30150-270

Oxion Hospital Dia Oncologia LTDA - Oxion, Belo Horizonte

98700-000

Centro

40170-110

Nucleo de Oncologia da Bahia, Salvador

01224-010

GRAM - Grupo de Assistencia Medica, São Paulo

T6G 1Z2

Cross Cancer Institute, Edmonton

V2S 0C2

BCCA - Abbotsford Centre, Abbotsford

V3V 1Z2

BCCA - Fraser Valley Cancer Centre, Surrey

V5Z 4E6

BCCA - Vancouver Cancer Centre, Vancouver

E2L 4L2

Atlantic Health Sciences Corporation, Saint John

A1B 3V6

Dr. H. Bliss Murphy Cancer Centre, St. John's

B3H 1V7

QEII Health Sciences Centre, Halifax

P3E 5J1

Health Sciences North, Greater Sudbury

L8V 5C2

Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton

K7L 5P9

Cancer Centre of Southeastern Ontario at Kingston, Kingston

N6A 4L6

London Regional Cancer Program, London

L1G 2B9

Lakeridge Health Oshawa, Oshawa

K1H 8L6

Ottawa Health Research Institute - General Division, Ottawa

P6B 0A8

Algoma District Cancer Program, Sault Ste. Marie

L2S 0A9

Niagara Health System, St. Catharines

M5G 2M9

Univ. Health Network-Princess Margaret Hospital, Toronto

N8W 2X3

Windsor Regional Cancer Centre, Windsor

H2L 4M1

CHUM - Hopital Notre-Dame, Montreal

H2W 1S6

McGill University - Dept. Oncology, Montreal

S4T 7T1

Allan Blair Cancer Centre, Regina

S7N 4H4

Saskatoon Cancer Centre, Saskatoon

00152

Azienda Ospedaliera S. Camillo-Forlanin, Rome

00161

Policlinico Umberto I, Universita Sapienza, Rome

443-721

Ajou University Hospital, Gyeonggi-do

519-763

Chonnan National University Hwasun Hospital, Jeongnam

120-752

Yonsei University College of Medicine, Seoul

134-791

Seoul Veterans Hospital, Seoul

137-701

The Catholic University of Korea,, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

NCIC Clinical Trials Group

NETWORK